Fingerprint
Dive into the research topics of 'Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma
N. Nora Bennani, Betsy R. LaPlant, Stephen M. Ansell, Thomas M. Habermann, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Joseph P. Colgan, Svetomir N. Markovic, Grzegorz S. Nowakowski, William R. Macon, Craig B. Reeder, Joseph R. Mikhael, Donald W. Northfelt, Irene M. Ghobrial, Thomas E. Witzig
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations